93 related articles for article (PubMed ID: 19101082)
1. HDAC inhibitors in models of inflammation-related tumorigenesis.
Glauben R; Sonnenberg E; Zeitz M; Siegmund B
Cancer Lett; 2009 Aug; 280(2):154-9. PubMed ID: 19101082
[TBL] [Abstract][Full Text] [Related]
2. The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods.
Curcio A; Rocca R; Alcaro S; Artese A
Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794190
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of histone deacetylases in ocular diseases.
Jun JH; Kim JS; Palomera LF; Jo DG
Arch Pharm Res; 2024 Jan; 47(1):20-39. PubMed ID: 38151648
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the Mysterious Relationship between the Cross-Pathogenetic Mechanisms of Neurodegenerative and Oncological Diseases.
Aleksandrova Y; Neganova M
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834214
[TBL] [Abstract][Full Text] [Related]
5. Discovery of New Uracil and Thiouracil Derivatives as Potential HDAC Inhibitors.
Elbatrawy OR; Hagras M; El Deeb MA; Agili F; Hegazy M; El-Husseiny AA; Mokhtar MM; Elkhawaga SY; Eissa IH; El-Kalyoubi S
Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513878
[No Abstract] [Full Text] [Related]
6. Protective Effect of Clostridium butyricum on Escherichia coli-Induced Endometritis in Mice via Ameliorating Endometrial Barrier and Inhibiting Inflammatory Response.
Wang K; Wang K; Wang J; Yu F; Ye C
Microbiol Spectr; 2022 Dec; 10(6):e0328622. PubMed ID: 36321897
[TBL] [Abstract][Full Text] [Related]
7. Vaginal Nanoformulations for the Management of Preterm Birth.
Mir A; Vartak RV; Patel K; Yellon SM; Reznik SE
Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297454
[TBL] [Abstract][Full Text] [Related]
8. Metformin and histone deacetylase inhibitor based anti-inflammatory nanoplatform for epithelial-mesenchymal transition suppression and metastatic tumor treatment.
Jiang T; Xie L; Zhou S; Liu Y; Huang Y; Mei N; Ma F; Gong J; Gao X; Chen J
J Nanobiotechnology; 2022 Aug; 20(1):394. PubMed ID: 36045429
[TBL] [Abstract][Full Text] [Related]
9. The function of Sphingosine-1-phosphate receptor 2 (S1PR2) in maintaining intestinal barrier and inducing ulcerative colitis.
Chen T; Gu K; Lin R; Liu Y; Shan Y
Bioengineered; 2022 May; 13(5):13703-13717. PubMed ID: 35707833
[TBL] [Abstract][Full Text] [Related]
10. Network Pharmacology Integrated Molecular Docking Revealed the Mechanism of Jianpi Yiqi Taohua Decoction Against Ulcerative Colitis.
Jia L; Zhou H; Li W; Lv Z
Med Sci Monit; 2022 Feb; 28():e933537. PubMed ID: 35173140
[TBL] [Abstract][Full Text] [Related]
11. Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends.
Nepali K; Liou JP
J Biomed Sci; 2021 Apr; 28(1):27. PubMed ID: 33840388
[TBL] [Abstract][Full Text] [Related]
12. Entinostat improves acute neurological outcomes and attenuates hematoma volume after Intracerebral Hemorrhage.
Bonsack F; Sukumari-Ramesh S
Brain Res; 2021 Feb; 1752():147222. PubMed ID: 33358731
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Histone Deacetylases Attenuates Morphine Tolerance and Restores MOR Expression in the DRG of BCP Rats.
He XT; Zhou KX; Zhao WJ; Zhang C; Deng JP; Chen FM; Gu ZX; Li YQ; Dong YL
Front Pharmacol; 2018; 9():509. PubMed ID: 29867508
[TBL] [Abstract][Full Text] [Related]
14. Determination and stress studies on YK-1101, a potential histone deacetylase, by HPLC-UV and HPLC-TOF/MS methods.
Zhou C; Liu WY; Feng F; Ye H; Wu CY
J Pharm Anal; 2013 Jun; 3(3):168-172. PubMed ID: 29403812
[TBL] [Abstract][Full Text] [Related]
15. The SphKs/S1P/S1PR1 axis in immunity and cancer: more ore to be mined.
Jin L; Liu WR; Tian MX; Fan J; Shi YH
World J Surg Oncol; 2016 Apr; 14():131. PubMed ID: 27129720
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic roles of epithelial and immune cell signaling during the development of colitis-associated cancer.
Subramaniam R; Mizoguchi A; Mizoguchi E
Cancer Res Front; 2016 Feb; 2(1):1-21. PubMed ID: 27110580
[TBL] [Abstract][Full Text] [Related]
17. The potential role of the NEK6, AURKA, AURKB, and PAK1 genes in adenomatous colorectal polyps and colorectal adenocarcinoma.
Kasap E; Gerceker E; Boyacıoglu SÖ; Yuceyar H; Yıldırm H; Ayhan S; Korkmaz M
Tumour Biol; 2016 Mar; 37(3):3071-80. PubMed ID: 26423403
[TBL] [Abstract][Full Text] [Related]
18. Selective, potent blockade of the IRE1 and ATF6 pathways by 4-phenylbutyric acid analogues.
Zhang H; Nakajima S; Kato H; Gu L; Yoshitomi T; Nagai K; Shinmori H; Kokubo S; Kitamura M
Br J Pharmacol; 2013 Oct; 170(4):822-34. PubMed ID: 23869584
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel compounds that enhance colon cancer cell sensitivity to inflammatory apoptotic ligands.
Chopra AS; Kuratnik A; Scocchera EW; Wright DL; Giardina C
Cancer Biol Ther; 2013 May; 14(5):436-49. PubMed ID: 23377828
[TBL] [Abstract][Full Text] [Related]
20. Low concentration of S100A8/9 promotes angiogenesis-related activity of vascular endothelial cells: bridges among inflammation, angiogenesis, and tumorigenesis?
Li C; Li S; Jia C; Yang L; Song Z; Wang Y
Mediators Inflamm; 2012; 2012():248574. PubMed ID: 22685372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
